WASHINGTON, July 13 — The figure that matters: Over 107,000 lives lost to drug overdoses in the U.S. in 2021. That is the scale of the crisis Dr. Nora Volkow has spent nearly a quarter-century trying to solve. By the numbers, Volkow has been the director of the National Institute on Drug Abuse (NIDA) since 2003.
She runs an agency with an annual budget exceeding $1.5 billion. Her own research output spans more than 700 peer-reviewed articles.
The bottom line: NIDA is betting on a new generation of tools, including vaccines, to turn the tide. Volkow is a psychiatrist and neuroscientist by training. She is known for her brain imaging studies of drug effects.
Under her leadership, NIDA has funded research on vaccines for substance use disorders. One of the most promising candidates is a fentanyl vaccine developed at the Scripps Research Institute.
The study was published on November 14, 2022, in the Journal of the American Chemical Society. Investors will note that this is not a speculative project — it is part of NIDA’s strategic priority to develop novel biomedical interventions for opioid use disorder. That priority aligns with the U.S. Department of Health and Human Services’ Overdose Prevention Strategy.
Volkow has been clear that vaccines are only one piece of the puzzle. She has emphasized the need for a range of tools to address the opioid crisis. That includes expanding access to medication-assisted treatment, or MAT, and harm reduction services.
Her career has not gone unnoticed. Volkow received the 2013 National Medal of Science, one of the highest honors a scientist can earn in the United States.
The fentanyl vaccine itself represents a shift in how researchers think about addiction treatment. A vaccine would train the immune system to recognize fentanyl and prevent it from reaching the brain, effectively neutralizing the drug before it can produce a high. Volkow’s agency has also funded research into vaccines for other substances, including cocaine and nicotine.
The fentanyl vaccine is the most advanced, given the urgency of the current crisis. The opioid epidemic has been driven largely by synthetic opioids like fentanyl.
The numbers are stark. The 107,000 overdose deaths in 2021 represent a staggering human cost. That figure has driven policy changes at the federal level, including the HHS Overdose Prevention Strategy, which explicitly includes biomedical interventions as a key component.
What to watch next: Clinical trials. The fentanyl vaccine has shown promise in animal studies. The next step is testing in humans.
If successful, it could become part of a broader toolkit that includes naloxone, MAT, and harm reduction services. Volkow has stressed that no single intervention will solve the crisis — but a vaccine could save thousands of lives each year.
The bottom line: NIDA is pushing forward with innovative science. Volkow has been at the helm for over two decades, and her agency is now funding research that could fundamentally change how the U.S. responds to the opioid epidemic. Consult your doctor for medical advice.
Sources
{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Dr. Volkow urges biomedical tools to fight opioid crisis”, “description”: “WASHINGTON, July 13 — The figure that matters: Over 107,000 lives lost to drug overdoses in the U.S. in 2021. That is the scale of…”, “datePublished”: “2026-07-13T09:30:00+00:00”, “author”: {“@type”: “Person”, “name”: “Ava Anderson”}, “publisher”: {“@type”: “Organization”, “name”: “InfoPulse Today”, “url”: “https://newsfeed.2bme.xyz/”}, “citation”: [{“@type”: “CreativeWork”, “url”: “https://en.wikipedia.org/wiki/Nora_Volkow”}]}
